Given Imaging to Host Third Quarter 2007 Earnings Conference Calls


YOQNEAM, ISRAEL--(Marketwire - October 17, 2007) - Given Imaging (NASDAQ: GIVN), the global leader in capsule endoscopy, today announced that the company will host conference calls on Thursday, November 1 to discuss third quarter 2007 financial results. The company plans to release results following the close of trading on Wednesday, October 31.

The company will host a conference call for English speakers at 9am ET on Thursday November 1. To participate in this teleconference, please dial (866) 409-1560 fifteen minutes before the conference is scheduled to begin. Callers outside of the U.S. should dial (913) 312-6690. The call will also be webcast live at www.givenimaging.com. A replay of the call will be available for two weeks on the company's website, or until November 15, 2007 by dialing (888) 203-1112. Callers outside of the U.S. should dial (719) 457-0820. The replay participant code is 6368714.

The company will host a separate conference call in Hebrew on November 1 at 9am Israel time. To access this call, please dial +972 3 9180609 fifteen minutes before the conference is scheduled to begin. A replay of the call will be available until November 6 by dialing +972 3 9255928.

About Given Imaging Ltd.

Given Imaging is redefining gastrointestinal diagnosis by developing, producing and marketing innovative, patient-friendly products for detecting gastrointestinal disorders. The company's technology platform is the PillCam® Platform, featuring the PillCam video capsule, a disposable, miniature video camera contained in a capsule, which is ingested by the patient, a sensor array, data recorder and RAPID® software. Given Imaging has three commercially available capsules: the PillCam SB video capsule to visualize the entire small intestine, which is currently marketed in the United States and in more than 60 other countries; the PillCam ESO video capsule to visualize the esophagus; and the Agile™ patency capsule to determine the free passage of the PillCam capsule in the GI tract. The PillCam COLON video capsule to visualize the colon has been cleared for marketing in the European Union, and multi-center clinical trials are underway in Europe and the U.S. More than 560,000 patients worldwide have benefited from the PillCam capsule endoscopy procedure. Given Imaging's headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel. It has operating subsidiary companies in the United States, Germany, France, Japan and Australia. For more information, visit http://www.givenimaging.com.

Contact Information: For further information contact: Fern Lazar David Carey Lazar Partners Ltd. 1-(866) GIVEN-IR